These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1221 related articles for article (PubMed ID: 30509268)

  • 81. Equivalent bronchodilation with budesonide/formoterol combination via Easyhaler and Turbuhaler in patients with asthma.
    Lähelmä S; Vahteristo M; Metev H; Taseva M; Stamatova N; Bartha A; Schlezák J; Sairanen U
    Respir Med; 2016 Nov; 120():31-35. PubMed ID: 27817813
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Baseline Symptom Score Impact on Benefits of Glycopyrrolate/Formoterol Metered Dose Inhaler in COPD.
    Martinez FJ; Fabbri LM; Ferguson GT; Orevillo C; Darken P; Martin UJ; Reisner C
    Chest; 2017 Dec; 152(6):1169-1178. PubMed ID: 28720336
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Study to Evaluate Satisfaction with the Inhalation Device Used by Patients with Asthma or Chronic Obstructive Pulmonary Disease and the Association with Adherence and Disease Control.
    Donaire JG; Pérez DD; Hernández C; Cabestre R
    J Aerosol Med Pulm Drug Deliv; 2020 Jun; 33(3):153-160. PubMed ID: 31834826
    [No Abstract]   [Full Text] [Related]  

  • 84. Combination therapy of inhaled steroids and long-acting beta2-agonists in asthma-COPD overlap syndrome.
    Lee SY; Park HY; Kim EK; Lim SY; Rhee CK; Hwang YI; Oh YM; Lee SD; Park YB
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2797-2803. PubMed ID: 27877033
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Assessment of inhalation technique among patients of chronic respiratory disorders in Civil Hospital Karachi: A cross sectional study.
    Farooq MZ; Farooq MS; Waqar W; Mustaqeem M; Khan JA; Saadullah S
    J Pak Med Assoc; 2016 Nov; 66(11):1502. PubMed ID: 27812082
    [TBL] [Abstract][Full Text] [Related]  

  • 86. The influence of type of inhalation device on adherence of COPD patients to inhaled medication.
    Koehorst-ter Huurne K; Movig K; van der Valk P; van der Palen J; Brusse-Keizer M
    Expert Opin Drug Deliv; 2016; 13(4):469-75. PubMed ID: 26666841
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Asthma-COPD overlap syndrome (ACOS) in primary care of four Latin America countries: the PUMA study.
    Montes de Oca M; Victorina Lopez Varela M; Laucho-Contreras ME; Casas A; Schiavi E; Mora JC
    BMC Pulm Med; 2017 Apr; 17(1):69. PubMed ID: 28431499
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Bronchodilator reversibility in asthma and COPD: findings from three large population studies.
    Janson C; Malinovschi A; Amaral AFS; Accordini S; Bousquet J; Buist AS; Canonica GW; Dahlén B; Garcia-Aymerich J; Gnatiuc L; Kowalski ML; Patel J; Tan W; Torén K; Zuberbier T; Burney P; Jarvis D
    Eur Respir J; 2019 Sep; 54(3):. PubMed ID: 31221806
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Pilot study of bronchodilator response to inhaled albuterol delivered by metered-dose inhaler and a novel dry powder inhaler.
    Kemp JP; Hill MR; Vaughan LM; Meltzer EO; Welch MJ; Ostrom NK
    Ann Allergy Asthma Immunol; 1997 Oct; 79(4):322-6. PubMed ID: 9357377
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Patient perception and acceptability of multidose dry powder inhalers: a randomized crossover comparison of Diskus/Accuhaler with Turbuhaler.
    Serra-Batlles J; Plaza V; Badiola C; Morejón E;
    J Aerosol Med; 2002; 15(1):59-64. PubMed ID: 12006146
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Knowledge of and technique for using inhalation devices among asthma patients and COPD patients.
    Souza ML; Meneghini AC; Ferraz E; Vianna EO; Borges MC
    J Bras Pneumol; 2009 Sep; 35(9):824-31. PubMed ID: 19820807
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Determinants and Differences in Satisfaction with the Inhaler Among Patients with Asthma or COPD.
    Plaza V; Giner J; Curto E; Alonso-Ortiz MB; Orue MI; Vega JM; Cosío BG;
    J Allergy Clin Immunol Pract; 2020 Feb; 8(2):645-653. PubMed ID: 31586668
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Risk Factors Associated with Misuse of Soft Mist Inhaler in Patients with Chronic Obstructive Pulmonary Disease.
    Jang JG; Lee YS; Hong KS; Ahn JH
    Int J Chron Obstruct Pulmon Dis; 2024; 19():1225-1232. PubMed ID: 38835808
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Pharmacokinetics and pharmacodynamics of fluticasone propionate and salmeterol delivered as a combination dry powder from a capsule-based inhaler and a multidose inhaler in asthma and COPD patients.
    Daley-Yates PT; Mehta R; Chan RH; Despa SX; Louey MD
    J Aerosol Med Pulm Drug Deliv; 2014 Aug; 27(4):279-89. PubMed ID: 24074143
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Assessment of the factors affecting the failure to use inhaler devices before and after training.
    Aydemir Y
    Respir Med; 2015 Apr; 109(4):451-8. PubMed ID: 25771037
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Physiological predictors Of peak inspiRatory flow using Observed lung function resultS (POROS): evaluation at discharge among patients hospitalized for a COPD exacerbation.
    Price DB; Yang S; Ming SWY; Hardjojo A; Cabrera C; Papaioannou AI; Loukides S; Kritikos V; Bosnic-Anticevich SZ; Carter V; Dorinsky PM
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3937-3946. PubMed ID: 30587952
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Inhalatory therapy training: a priority challenge for the physician.
    Melani AS
    Acta Biomed; 2007 Dec; 78(3):233-45. PubMed ID: 18330086
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Requirements, Strengths and Weaknesses of Inhaler Devices for COPD Patients from the Expert Prescribers' Point of View: Results of the EPOCA Delphi Consensus.
    García-Río F; Soler-Cataluña JJ; Alcazar B; Viejo JL; Miravitlles M
    COPD; 2017 Dec; 14(6):573-580. PubMed ID: 28891722
    [TBL] [Abstract][Full Text] [Related]  

  • 99. A Method to Calculate Adherence to Inhaled Therapy that Reflects the Changes in Clinical Features of Asthma.
    Sulaiman I; Seheult J; MacHale E; Boland F; O'Dwyer SM; Rapcan V; D'Arcy S; Cushen B; Mokoka M; Killane I; Ryder SA; Reilly RB; Costello RW
    Ann Am Thorac Soc; 2016 Nov; 13(11):1894-1903. PubMed ID: 27467125
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Asthma and COPD: Interchangeable use of inhalers. A document of Italian Society of Allergy, Asthma and Clinical Immmunology (SIAAIC) & Italian Society of Respiratory Medicine (SIMeR).
    Lavorini F; Braido F; Baiardini I; Blasi F; Canonica GW;
    Pulm Pharmacol Ther; 2015 Oct; 34():25-30. PubMed ID: 26209820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 62.